Steven Seedhouse

Stock Analyst at Raymond James

(0.87)
# 2297
Out of 5,380 analysts
264
Total ratings
Success rate
Average return
40 Stocks
Name Action PT Current % Upside Ratings Updated
MIRM Mirum Pharmaceutical...
Maintains: Strong Buy
73 77
51.12 50.63% 19 May 13, 2025
WVE WAVE Life Sciences
Initiates Coverage On: Overweight
10
6.86 45.77% 3 Apr 29, 2025
KRRO Korro Bio
Initiates Coverage On: Overweight
74
12.68 483.6% 2 Apr 29, 2025
PHVS Pharvaris
Initiates Coverage On: Overweight
28
17.4 60.92% 1 Apr 29, 2025
ATXS Astria Therapeutics
Initiates Coverage On: Overweight
47
5.73 720.24% 1 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
10
0.78 1182.05% 14 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
20
9.92 101.61% 1 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
104
27 285.19% 19 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Outperform
90 22
1.59 1283.65% 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
51 56
18.13 208.88% 3 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
53 49
9.79 400.51% 10 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
6 14
2.02 593.07% 6 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
93
107.18 -13.23% 9 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
57 68
22.56 201.42% 3 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 11 Mar 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
33 33
n/a n/a 12 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
67 106
18.61 469.59% 15 Jan 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 15
3.67 308.72% 2 Jan 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
27 56
10.62 427.31% 4 Jan 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
19 18
n/a n/a 8 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 57
9.6 493.75% 10 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
20 22
1.2 1733.33% 2 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
17
2.25 655.56% 6 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 17 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
33 35
2.77 1163.54% 4 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
38
47.16 -19.42% 2 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 6
n/a n/a 7 Apr 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 10 Feb 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
30 71
29.91 137.38% 4 Dec 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 5
1.39 259.71% 5 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 38
23.32 62.95% 2 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Aug 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 7 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 14 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 May 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
285 270
15.06 1692.83% 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 10
n/a n/a 3 Mar 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 10 Jan 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 2 Apr 23, 2020